Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Bi 690517

Contact Research Centre

Ischaemic stroke

Recruiting

Investigational

Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:JX10

Contact Research Centre

Cardiac failure chronic+1

Recruiting

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Recruiting

Registered drugNo placebo

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Generalised anxiety disorder

Recruiting

Investigational

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Iti-1284

Contact Research Centre

Progressive multiple sclerosis

Recruiting

Investigational

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Investigational

Bulgaria

Participants:18–64 years
Substances:Vidofludimus Calcium

Contact Research Centre

Clostridium difficile infection

Recruiting

Investigational

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Find therapies in clinical trials near you – page 3

99 trials match your criteria

Arteriosclerosis

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Varicella

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Hypertriglyceridaemia

Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Cardiac failure

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Ischaemic stroke

Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

Cardiac failure chronic+1

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Non-small cell lung cancer

Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Study of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer

Generalised anxiety disorder

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

Progressive multiple sclerosis

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Clostridium difficile infection

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Non-small cell lung cancer

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.